IP Library › Granted Patent US 10,351,892
Granted Patent B2
US 10,351,892 · App. 15/337,630 · Granted Jul 16, 2019

Mutant-type glucose dehydrogenase and use thereof

Inventors: Katsuhiro Kojima (Tokyo, JP); Kazushige Mori (Tokyo, JP)
Assignees: ARKRAY, Inc.; Ultizyme International Ltd.
C12Q1/006C12N9/0006C12Y101/9901G01N2333/904
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,351,892
App. No.
15/337,630
Granted
Jul 16, 2019
Kind
B2
Abstract

The present invention provides a mutant-type glucose dehydrogenase having glucose dehydrogenase activity and having decreased reactivity with xylose, wherein said mutant-type glucose dehydrogenase comprises a mutant-type α-subunit comprising an amino acid sequence of 520 to 550 amino acids comprising an amino acid sequence of 520 to 550 amino acids comprising SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24 and SEQ ID NO: 25 in this order from N-terminus to C-terminus, except that one or more amino acid residue(s) selected from the group consisting of the glycine at position 10 in SEQ ID NO: 23, the histidine at position 4 in SEQ ID NO: 24, and the asparagine at position 4 in SEQ ID NO: 25 is/are substituted with another/other amino acid(s).

Claims (20)

1. A mutant glucose dehydrogenase having glucose dehydrogenase activity and decreased reactivity with xylose compared to a wild glucose dehydrogenase comprising the polypeptides of SEQ ID NO: 2, 3, and 6,

wherein said mutant glucose dehydrogenase comprises a mutant α-subunit having an amino acid sequence at least 93% identical to SEQ ID NO: 3, 7, 8, 9 or 10, wherein said mutant α-subunit comprises SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24 and SEQ ID NO: 25 in this order from N-terminus to C-terminus, except that the asparagine at position 4 in SEQ ID NO: 25 is substituted with another amino acid.

2. A mutant glucose dehydrogenase having glucose dehydrogenase activity and decreased reactivity with xylose compared to a wild glucose dehydrogenase comprising the polypeptides of SEQ ID NO: 2, 3, and 6,

wherein said mutant glucose dehydrogenase comprises a mutant α-subunit having an amino acid sequence at least 93% identical to SEQ ID NO: 3, 7, 8, 9 or 10, wherein said mutant α-subunit comprises SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24 and SEQ ID NO: 25 in this order from N-terminus to C-terminus, except that

the asparagine at position 4 in SEQ ID NO: 25 is substituted with another amino acid, and

the amino acid residue(s) corresponding to at least one amino acid residue selected from the group consisting of Met at position 8 in SEQ ID NO: 22, Gly at position 10 in SEQ ID NO: 23, Gly at position 12 in SEQ ID NO: 23, His at position 4 in SEQ ID NO: 24, Ser at position 6 in SEQ ID NO: 24, Ala at position 2 in SEQ ID NO: 25, Pro or Asn at position 3 in SEQ ID NO: 25, Asn at position 5 in SEQ ID NO: 25 and Ile at position 7 in SEQ ID NO: 25 is/are substituted with another/other amino acid residue(s).

3. The mutant glucose dehydrogenase according to claim 1 , further having decreased reactivity with galactose compared to a wild-type glucose dehydrogenase comprising the polypeptides of SEQ ID NO: 2, 3 and 6.

4. The mutant type glucose dehydrogenase according to claim 1 , wherein said mutant α-subunit comprises an amino acid sequence at least 96% identical to an amino acid sequence selected from the group consisting of SEQ ID NO: 3 and 7-10.

5. The mutant glucose dehydrogenase according to claim 1 , wherein the mutant α-subunit comprises an amino acid sequence selected from the group consisting of SEQ ID NO: 3 and 7-10, except that the asparagine at position 4 in SEQ ID NO: 25 is substituted with another amino acid and one amino acid in SEQ ID NO: 3, 7, 8, 9, or 10 is substituted, deleted, inserted and/or added.

6. A mutant glucose dehydrogenase having glucose dehydrogenase activity and decreased reactivity with xylose compared to a wild glucose dehydrogenase comprising the polypeptides of SEQ ID NO: 2, 3, and 6,

wherein said mutant glucose dehydrogenase comprises a mutant α-subunit having an amino acid sequence at least 93% identical to SEQ ID NO: 3,

wherein the amino acid residue corresponding to the asparagine at position 474 in SEQ ID NO: 3 is substituted with serine; the amino acid residue corresponding to the glycine at position 322 in SEQ ID NO: 3 is substituted with glutamine; the amino acid residue corresponding to the histidine at position 363 in SEQ ID NO: 3 is substituted with glutamine or serine; and the amino acid residue corresponding to the asparagine at position 475 in SEQ ID NO: 3 is substituted with serine.

7. The mutant glucose dehydrogenase according to claim 1 , further comprising an electron transfer subunit.

8. The mutant glucose dehydrogenase according to claim 7 , wherein said electron transfer subunit is cytochrome c.

9. A glucose assay kit comprising the mutant glucose dehydrogenase according to claim 1 .

10. A glucose sensor comprising the mutant glucose dehydrogenase according to claim 1 .

11. The mutant glucose dehydrogenase according to claim 6 , wherein said mutant α-subunit comprises the amino acid sequence of SEQ ID NO: 3, except that the amino acid residue corresponding to the asparagine at position 474 in SEQ ID NO: 3 is substituted with serine; the amino acid residue corresponding to the glycine at position 322 in SEQ ID NO: 3 is substituted with glutamine; the amino acid residue corresponding to the histidine at position 363 in SEQ ID NO: 3 is substituted with glutamine or serine; and the amino acid residue corresponding to the asparagine at position 475 in SEQ ID NO: 3 is substituted with serine.

12. A mutant glucose dehydrogenase having glucose dehydrogenase activity and decreased reactivity with xylose compared to a wild glucose dehydrogenase comprising the polypeptides of SEQ ID NO: 2, 3, and 6,

wherein said mutant glucose dehydrogenase comprises a mutant α-subunit having an amino acid sequence at least 93% identical to SEQ ID NO: 3, 7, 8, 9 or 10, wherein said mutant α-subunit comprises SEQ ID NO: 21, SEQ ID NO: 22, SEQ ID NO: 23, SEQ ID NO: 24 and SEQ ID NO: 25 in this order from N-terminus to C-terminus, except that the glycine at position 10 in SEQ ID NO: 23, the histidine at position 4 in SEQ ID NO: 24, and the asparagine at position 4 in SEQ ID NO: 25 are substituted with other amino acids.

13. The mutant glucose dehydrogenase according to claim 12 , wherein said mutant α-subunit an amino acid sequence at least 96% identical to an amino acid sequence selected from the group consisting of SEQ ID NO: 3 and 7-10.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2023
From: ULTIZYME INTERNATIONAL LTD.
To: ARKRAY, INC.
Reel/Frame 062675/0251 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 22, 2016
From: KOJIMA, KATSUHIRO; MORI, KAZUSHIGE
To: ARKRAY, INC.; ULTIZYME INTERNATIONAL LTD.
Reel/Frame 040741/0060 →
Priority Claims (1)
JP 2015-213085 · Oct 29, 2015 · national
Continuity (1)
Related Publication 20170121751A1 · May 4, 2017